Paradigm Medical Ind
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P22… Read more
Paradigm Medical Ind (PDMI) - Net Assets
Latest net assets as of June 2012: $-2.66 Million USD
Based on the latest financial reports, Paradigm Medical Ind (PDMI) has net assets worth $-2.66 Million USD as of June 2012.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($816.00K) and total liabilities ($3.48 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.66 Million |
| % of Total Assets | -326.23% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -187.99% |
| Growth Volatility | 285.51 |
Paradigm Medical Ind - Net Assets Trend (1995–2011)
This chart illustrates how Paradigm Medical Ind's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Paradigm Medical Ind (1995–2011)
The table below shows the annual net assets of Paradigm Medical Ind from 1995 to 2011.
| Year | Net Assets | Change |
|---|---|---|
| 2011-12-31 | $-2.50 Million | -4.20% |
| 2010-12-31 | $-2.40 Million | +26.73% |
| 2009-12-31 | $-3.28 Million | +12.69% |
| 2008-12-31 | $-3.76 Million | -75.61% |
| 2007-12-31 | $-2.14 Million | -11.17% |
| 2006-12-31 | $-1.93 Million | -27.23% |
| 2005-12-31 | $-1.51 Million | -319.28% |
| 2004-12-31 | $690.00K | +1.47% |
| 2003-12-31 | $680.00K | -76.12% |
| 2002-12-31 | $2.85 Million | -70.56% |
| 2001-12-31 | $9.67 Million | +9.84% |
| 2000-12-31 | $8.80 Million | +42.00% |
| 1999-12-31 | $6.20 Million | +264.71% |
| 1998-12-31 | $1.70 Million | +466.67% |
| 1997-12-31 | $300.00K | -92.50% |
| 1996-12-31 | $4.00 Million | +700.00% |
| 1995-12-31 | $500.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Paradigm Medical Ind's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7270.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2011)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.77 Million | % |
| Other Components | $59.25 Million | % |
| Total Equity | $-2.50 Million | 100.00% |
Paradigm Medical Ind Competitors by Market Cap
The table below lists competitors of Paradigm Medical Ind ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Drone Services USA Inc
PINK:DSUS
|
$0.98 |
|
Integral Vision Inc
PINK:INVI
|
$0.98 |
|
Click To Raffle.Com Inc
PINK:AQFD
|
$0.98 |
|
Wake Up Now Inc
PINK:WORC
|
$0.98 |
|
PPJ Healthcare Enterprises Inc
PINK:PPJE
|
$0.98 |
|
American Environmental Inc
PINK:MZPS
|
$0.98 |
|
Horizons Holdings International Corp
PINK:HZHI
|
$0.98 |
|
Enable IPC Corporation
OTCGREY:EIPC
|
$0.98 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Paradigm Medical Ind's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2010 to 2011, total equity changed from -2,404,000 to -2,505,000, a change of -101,000.
- Net loss of 474,000 reduced equity.
- Other factors increased equity by 373,000.
Equity Change Factors (2010 to 2011)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-474.00K | -18.92% |
| Other Changes | $373.00K | +14.89% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Paradigm Medical Ind's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $1557.63 | $0.00 | x |
| 1996-12-31 | $12461.06 | $0.00 | x |
| 1997-12-31 | $791.56 | $0.00 | x |
| 1998-12-31 | $3165.74 | $0.00 | x |
| 1999-12-31 | $6275.30 | $0.00 | x |
| 2000-12-31 | $7629.12 | $0.00 | x |
| 2001-12-31 | $7303.63 | $0.00 | x |
| 2002-12-31 | $1605.75 | $0.00 | x |
| 2003-12-31 | $282.74 | $0.00 | x |
| 2004-12-31 | $249.46 | $0.00 | x |
| 2005-12-31 | $-352.35 | $0.00 | x |
| 2006-12-31 | $-109.44 | $0.00 | x |
| 2007-12-31 | $-80.84 | $0.00 | x |
| 2008-12-31 | $-32.98 | $0.00 | x |
| 2009-12-31 | $-0.29 | $0.00 | x |
| 2010-12-31 | $-0.05 | $0.00 | x |
| 2011-12-31 | $-0.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Paradigm Medical Ind utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -61.40%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-141.71%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | -160.00% | -160.00% | 0.56x | 1.80x | $-850.00K |
| 1996 | -35.00% | -466.67% | 0.07x | 1.05x | $-1.80 Million |
| 1997 | -933.33% | -560.00% | 0.20x | 8.33x | $-2.83 Million |
| 1998 | -164.71% | -215.38% | 0.59x | 1.29x | $-2.97 Million |
| 1999 | -58.06% | -211.76% | 0.26x | 1.06x | $-4.22 Million |
| 2000 | -105.69% | -116.47% | 0.75x | 1.22x | $-10.19 Million |
| 2001 | -104.89% | -128.08% | 0.63x | 1.31x | $-11.11 Million |
| 2002 | -391.82% | -207.81% | 1.01x | 1.86x | $-11.44 Million |
| 2003 | -464.85% | -103.33% | 1.05x | 4.30x | $-3.23 Million |
| 2004 | 9.28% | 2.09% | 1.30x | 3.42x | $-5.00K |
| 2005 | 0.00% | -244.84% | 1.29x | 0.00x | $-5.24 Million |
| 2006 | 0.00% | -82.73% | 1.14x | 0.00x | $-1.62 Million |
| 2007 | 0.00% | -92.47% | 0.86x | 0.00x | $-1.52 Million |
| 2008 | 0.00% | -137.33% | 1.00x | 0.00x | $-1.35 Million |
| 2009 | 0.00% | -110.72% | 0.85x | 0.00x | $-621.90K |
| 2010 | 0.00% | -133.33% | 0.73x | 0.00x | $-727.60K |
| 2011 | 0.00% | -61.40% | 0.86x | 0.00x | $-223.50K |
Industry Comparison
This section compares Paradigm Medical Ind's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Paradigm Medical Ind (PDMI) | $-2.66 Million | -160.00% | N/A | $0.98 |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |